Electric Field Therapy as an Alternative Medicine in the Clinical Management of Cancer

Author(s): Michael D. Stine

The company Novocure has developed a viable chemotherapy alternative in the form of electric field therapy. This Novocure product has been given FDA approval for recurrent glioblastoma. However, they currently have Phase I, Phase II and Phase III clinical trials underway for a variety of other cancers. The treatment is a noninvasive monotherapy and incorporates Tumor Treating Fields to interrupt mitotic division in rapidly dividing cells with a low number of adverse effects. Dr. Palti spearheaded this product and has outreached to over 2,200 patients, allowing them to receive treatment without major lifestyle modifications.

1. American Cancer Society, Inc. Cancer Facts and Figures 2014 [Internet]. 2014 [cited May 2 2015]. Available from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
2. American Cancer Society, Inc, Evolution of cancer treatments: Chemotherapy [Internet]. 2014 [cited May 4 2015]. Available from: http://www.cancer.org/cancer/cancerbasics/thehistoryofcancer/the-history-of-cancer-cancer-treatment-chemo
3. American Cancer Society, Inc. Evolution of cancer treatments: Surgery [Internet]. 2014 [cited May 4 2015]. Available from: http://www.cancer.org/cancer/cancerbasics/thehistoryofcancer/the-history-of-cancer-cancer-treatment-surgery
4. American Cancer Society, Inc, Evolution of cancer treatments: Radiation [Internet]. 2014 [cited May 4 2015]. Available from: http://www.cancer.org/cancer/cancerbasics/thehistoryofcancer/the-history-of-cancer-cancer-treatment-radiation
5. Novocure. Our History [Internet]. 2015 [cited 2015 May 2 2015]. Available from: http://www.novocure.com/about-us/our-history.aspx
6. Davies AM, Weinber U, Palti Y (2103) Tumor treating fields: a new frontier in cancer therapy. Ann N Y Acad Sci. 1291:86-95. http://www.ncbi.nlm.nih.gov/pubmed/23659608
7. FDA. Summary of Safety and Effectiveness Data (SSED) on NovoTTF-100A System [Internet]. 2012 Dec 6 [cited 2015 May 2 2015]. Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf10/p100034b.pdf
8. Optune™. Explore the System [Internet]. 2014 [cited 2015 May 2 2015]. Available from: http://www.optune.com/therapy/explore-therapy.aspx
9. Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzhaki A, et al. (2004) Disruption of cancer cell replication by alternating electric fields. Cancer Res. 64(9):3288-95. http://www.ncbi.nlm.nih.gov/pubmed/15126372
10. Giladi M, Weinberg U, Schneiderman RS, Porat Y, Munster M, et al. (2014) Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo. Semin Oncol. Suppl 6:S35-41. http://www.ncbi.nlm.nih.gov/pubmed/25213867
11. Novocure. Our Therapy [Internet]. 2014 [cited May 2, 2015]. Available from: http://www.novocure.com/our-therapy.aspx
12. Novocure. Our Pipeline [Internet]. 2015 [cited 2015 May 2 2015]. Available from: http://www.novocure.com/our-pipeline.aspx
13. Fonkem E, Wong ET (2012) NovoTTF-100A: a new treatment modality for recurrent glioblastoma. Expert review of neurotherapeutics 12(8):895-9. http://www.ncbi.nlm.nih.gov/pubmed/22708931
14. Eilin DK, Moshe G, Zoya G, Aviran I, Daniel M, et al. (2009) Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs. Clinical & Experimental Metastasis 26(7):633-640. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776150/
15. Novocure. [Internet]. 2014 [cited May 7 2015]. Available from: http://www.novocure.com
16. Optune™. Instructions for Use [Internet]. 2014 Nov [cited 2015 May 2 2015]. Available from: http://www.optune.com/Content/pdfs/Optune_IFU_8.5x11.pdf
17. Lacouture ME, Davis ME, Elazinga G, Butowski N, Tran D, et al. (2014) Characterization and management of dermatological adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma. Semin Oncol. Volume 41 Suppl 4:S1-S14 http://www.ncbi.nlm.nih.gov/pubmed/24794308
18. Optune™. Applying Transducer Arrays [Internet]. 2014 [cited May 2 2015]. Available from: http://www.optune.com/how-to-use/applying-arrays.aspx
19. FDA. Executive Summary P100034 NovoCure Ltd. USA [Internet]. 2011 Mar. 17 [cited 2015 May 2 2015]. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM247246.doc